Life Science REIT (LABS) Share Price, News & Analysis GBX 59.80 -2.40 (-3.86%) (As of 12/8/2023 ET) Add Share Share Today's Range 59.60▼ 62.6050-Day Range 59.80▼ 72.4052-Week Range 58▼ 77.40Volume656,385 shsAverage Volume746,248 shsMarket Capitalization£209.30 millionP/E RatioN/ADividend Yield6.69%Price TargetGBX 114 Stock AnalysisStock AnalysisAnalyst ForecastsChartDividendStock AnalysisAnalyst ForecastsChartDividend LABS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LABS Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive LABS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Life Science REIT and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 10/31 Dividend9/28/2023Dividend Payable10/31/2023Today12/10/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON Industry N/A Sub-IndustryN/A SectorN/A Current SymbolLON:LABS CUSIPN/A CIKN/A Webwww.lifesciencereit.co.uk PhoneN/AFaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price TargetGBX 114 High Stock Price TargetGBX 114 Low Stock Price TargetGBX 114 Potential Upside/Downside+90.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)GBX (0.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-29,190,000.00 Net Margins-151.24% Pretax MarginN/A Return on Equity-8.24% Return on Assets0.82% Debt Debt-to-Equity Ratio31.91 Current Ratio1.35 Quick RatioN/A Sales & Book Value Annual Sales£19.30 million Price / Sales10.84 Cash FlowN/A Price / Cash FlowN/A Book ValueGBX 90 per share Price / Book0.66Miscellaneous Outstanding Shares350,000,000Free FloatN/AMarket Cap£209.30 million OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesDr. Sally Ann Forsyth O.B.E.Ph.D., Independent Non-Exec. Director & Sustainability LeadMr. Simon Farnsworth (Age 56)Managing Director of Ironstone Asset Management Limited Mr. David LewisDirector of Operations & Fin. of Ironstone Asset Management LimitedMs. Joanna WaddinghamHead of Investor Relations & Corp. Affairs of Ironstone Asset Management LimitedMs. Stephanie AdamsLegal Counsel of Ironstone Asset Management LimitedMr. Ian HarrisDirector of Asset Management of Ironstone Asset Management LimitedMs. Pippa StaceyHead of ESG & Consultant of Ironstone Asset Management LimitedTamara DeeringHead of Financial Planning & Reporting of Ironstone Asset Management LimitedMr. Daniel WilliamsCorp. & Devel. Financial Controller - Ironstone Asset Management LimitedMore Executives LABS Stock Analysis - Frequently Asked Questions Should I buy or sell Life Science REIT stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Life Science REIT in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" LABS shares. View LABS analyst ratings or view top-rated stocks. What is Life Science REIT's stock price target for 2024? 1 equities research analysts have issued twelve-month target prices for Life Science REIT's shares. Their LABS share price targets range from GBX 114 to GBX 114. On average, they predict the company's stock price to reach GBX 114 in the next twelve months. This suggests a possible upside of 90.6% from the stock's current price. View analysts price targets for LABS or view top-rated stocks among Wall Street analysts. How have LABS shares performed in 2023? Life Science REIT's stock was trading at GBX 72.30 at the start of the year. Since then, LABS stock has decreased by 17.3% and is now trading at GBX 59.80. View the best growth stocks for 2023 here. How often does Life Science REIT pay dividends? What is the dividend yield for Life Science REIT? Life Science REIT declared a dividend on Thursday, September 21st. Shareholders of record on Thursday, September 28th will be paid a dividend of GBX 1 per share on Tuesday, October 31st. This represents a yield of 1.39%. The ex-dividend date is Thursday, September 28th. The official announcement can be accessed at this link. Read our dividend analysis for LABS. Is Life Science REIT a good dividend stock? Life Science REIT (LON:LABS) pays an annual dividend of GBX 4 per share and currently has a dividend yield of 5.95%. LABS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for LABS. How do I buy shares of Life Science REIT? Shares of LABS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:LABS) was last updated on 12/10/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Life Science REIT Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.